[Federal Register Volume 86, Number 220 (Thursday, November 18, 2021)]
[Notices]
[Pages 64452-64453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25186]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-55-2021]


Foreign-Trade Zone (FTZ) 22--Chicago, Illinois; Authorization of 
Production Activity AbbVie, Inc. (Pharmaceutical Products) North 
Chicago and Lake County, Illinois

    On July 16, 2021, AbbVie, Inc., submitted a notification of 
proposed production activity to the FTZ Board for its facilities within 
Subzone 22S, in North Chicago and Lake County, Illinois.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 41008, July 30, 2021). On 
November 15, 2021, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time.

[[Page 64453]]

The production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: November 15, 2021.
Camille Evans,
Acting Executive Secretary.
[FR Doc. 2021-25186 Filed 11-17-21; 8:45 am]
BILLING CODE 3510-DS-P